LeapFinancial | $3,500,000 | (Dec 20, 2024)
TG0 | $5,619,170 | (Dec 20, 2024)
Mindgard | $8,000,000 | (Dec 20, 2024)
Sentante
Lithuania
- Kaunas
- 22/12/2023
- Seed
- $6,605,760
Developing robotic system for endovascular procedures - Sentante – a smart, sensory, teleoperated robot system which allows the procedure to be performed remotely, from a different room, thus protecting physicians from harmful X-rays and opening up tele-surgery possibilities. For more information, please visit our website: https://sentante.com/
Sentante is designed to be controlled in the same way as a manually performed endovascular procedure – by using the conventional endovascular instruments –guidewires and catheters.
The proprietary patented technology is able to “sense” operators’ movements and provide close to natural haptic force feedback ensuring intuitive control of endovascular instruments – while operating remotely, physicians can still feel the catheter and guidewire resistance just as if they were standing near the patient.
- Industry Medical Equipment Manufacturing
- Website http://www.sentante.com/
- LinkedIn https://www.linkedin.com/company/inovatyvi-medicina/
Related People
Edvardas SatkauskasFounder
Lithuania -
ND
Executive and entrepreneur with >15 years of experience in innovative product development
ŌURA | $200,000,000 | (Dec 20, 2024)
Buildpeer | $2,500,000 | (Dec 20, 2024)
Embeddable | $6,238,050 | (Dec 20, 2024)
Tenor | $5,400,000 | (Dec 20, 2024)
SOTELIX Endoscopy | $1,700,000 | (Dec 20, 2024)
Double(US) | $3,900,000 | (Dec 20, 2024)
Hauler Hero | $10,000,000 | (Dec 20, 2024)
TripSuite | $5,000,000 | (Dec 20, 2024)
Seekho | $8,000,000 | (Dec 19, 2024)